Tokyo Tape
Sign in
← Astellas Pharma

Annual report

4503.TEDINET S100SMI3
Period2022-04-01 → 2023-03-31
Filed2024-01-16
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed

Amends S100R0I6. Amended by S100SMT5 (2024-01-16).

Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥1.52T2022-04-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥1.30T2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥1.25T2020-04-01 → 2021-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥1.30T2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥1.31T2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥133.0bn2022-04-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥155.7bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax¥132.4bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥156.9bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥145.3bn2020-04-01 → 2021-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥245.3bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥249.0bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥98.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥124.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥120.6bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥195.4bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥222.3bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥98.7bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥124.1bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥2.46Tat 2023-03-31Cons.Assets IFRS
Total assets¥2.33Tat 2022-03-31Cons.Assets IFRS
Total assets¥2.27Tat 2021-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥2.32Tat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥1.90Tat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥948.6bnat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥872.1bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.51Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥1.46Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.39Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.51Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.39Tat 2021-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.29Tat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.26Tat 2019-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥376.8bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥316.0bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥326.1bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥318.4bnat 2020-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥311.1bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥327.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥257.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥306.8bn2020-04-01 → 2021-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥222.0bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥258.6bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥84.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥62.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥81.9bn2020-04-01 → 2021-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥389.8bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥41.8bn2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥195.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥216.3bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥229.5bn2020-04-01 → 2021-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥181.1bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥233.7bn2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥54.242022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥67.082021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥64.932020-04-01 → 2021-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥104.152019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥115.052018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥54.092022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.052021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥64.92020-04-01 → 2021-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥104.082019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥114.942018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥839.26at 2023-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥799.26at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥748.03at 2021-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥694.03at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥667.29at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio61.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio61.0%at 2021-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio55.7%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio66.3%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE6.7%2022-04-01 → 2023-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE8.7%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE9.0%2020-04-01 → 2021-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE15.3%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE17.6%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees14,484at 2023-03-31Cons.Number of employees
Employees14,522at 2022-03-31Cons.Number of employees
Employees15,455at 2021-03-31dCons.Number of employees
Employees15,883at 2020-03-31dCons.Number of employees
Employees16,243at 2019-03-31dCons.Number of employees
Revenue¥613.6bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥542.6bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥545.6bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥600.6bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥607.3bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Operating income¥130.6bn2022-04-01 → 2023-03-31StandaloneOperating income
Operating income¥105.9bn2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income¥338.2bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥270.5bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥223.4bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥293.2bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥209.7bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥348.1bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax¥254.1bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income¥314.2bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥225.1bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥193.1bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥240.6bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥178.7bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.49Tat 2023-03-31StandaloneAssets
Total assets¥1.39Tat 2022-03-31StandaloneAssets
Total assets¥1.35Tat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.33Tat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.23Tat 2019-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥466.1bnat 2023-03-31StandaloneLiabilities
Total liabilities¥514.9bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥1.02Tat 2023-03-31StandaloneNet assets
Net assets / equity¥873.6bnat 2022-03-31StandaloneNet assets
Net assets / equity¥787.7bnat 2021-03-31dStandaloneNet assets
Net assets / equity¥671.6bnat 2020-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥565.6bnat 2019-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥217.0bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥184.0bnat 2022-03-31StandaloneCash and deposits
EPS (basic)¥172.642022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥121.692021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥103.952020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥128.262019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥92.492018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥172.572022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥121.632021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥103.892020-04-01 → 2021-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥128.172019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥92.42018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥602022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥502021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥422020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥402019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥382018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥568.97at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥477.81at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥424.69at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥361.08at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥299.34at 2019-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio68.7%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio62.9%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio58.3%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio50.4%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio45.8%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE33.2%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE27.1%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE26.5%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE39.0%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE30.4%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued1,809,663,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,835,852,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,861,787,000at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,861,787,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,979,823,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees4,867at 2023-03-31StandaloneNumber of employees
Employees3,943at 2022-03-31StandaloneNumber of employees
Employees4,647at 2021-03-31dStandaloneNumber of employees
Employees4,560at 2020-03-31dStandaloneNumber of employees
Employees5,034at 2019-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceuticalreportable segmentemployeesat 2023-03-3114484 pure
Pharmaceuticalreportable segmentemployeesat 2023-03-314867 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,666
ItemContextValueUnit
Change in fair value of contingent considerations income IFRSPrior1YearDuration5369000000JPY
Change in fair value of contingent considerations income IFRSCurrentYearDuration2337000000JPY
Foreign exchange gain IFRSPrior1YearDuration8172000000JPY
Foreign exchange gain IFRSCurrentYearDuration－JPY
Other other income IFRSPrior1YearDuration1715000000JPY
Other other income IFRSCurrentYearDuration1305000000JPY
Other income IFRSPrior1YearDuration15256000000JPY
Other income IFRSCurrentYearDuration3642000000JPY
Impairment losses for goodwill other expenses IFRSPrior1YearDuration5173000000JPY
Impairment losses for goodwill other expenses IFRSCurrentYearDuration－JPY
Impairment losses for intangible asssets other expenses IFRSPrior1YearDuration69015000000JPY
Impairment losses for intangible asssets other expenses IFRSCurrentYearDuration83964000000JPY
Change in fair value of contingent considerations IFRSPrior1YearDuration7049000000JPY
Change in fair value of contingent considerations IFRSCurrentYearDuration53059000000JPY
Restructuring expenses IFRSPrior1YearDuration19556000000JPY
Restructuring expenses IFRSCurrentYearDuration4510000000JPY
Loss on litigation IFRSPrior1YearDuration948000000JPY
Loss on litigation IFRSCurrentYearDuration1497000000JPY
Foreign exchange loss IFRSPrior1YearDuration－JPY
Foreign exchange loss IFRSCurrentYearDuration10124000000JPY
Other other expenses IFRSPrior1YearDuration2573000000JPY
Other other expenses IFRSCurrentYearDuration4360000000JPY
Other expenses IFRSPrior1YearDuration104314000000JPY
Other expenses IFRSCurrentYearDuration157515000000JPY
Interest income IFRSPrior1YearDuration794000000JPY
Interest income IFRSCurrentYearDuration5209000000JPY
Investments derecognized during the year financial assets measured at fair value through other comprehensive income dividend income IFRSPrior1YearDuration22000000JPY
Investments derecognized during the year financial assets measured at fair value through other comprehensive income dividend income IFRSCurrentYearDuration6000000JPY
Investments held at the end of the year financial assets measured at fair value through other comprehensive income dividend income IFRSPrior1YearDuration46000000JPY
Investments held at the end of the year financial assets measured at fair value through other comprehensive income dividend income IFRSCurrentYearDuration38000000JPY
Gain on valuation of investments in funds IFRSPrior1YearDuration5084000000JPY
Gain on valuation of investments in funds IFRSCurrentYearDuration152000000JPY
Other finance income IFRSPrior1YearDuration203000000JPY
Other finance income IFRSCurrentYearDuration2706000000JPY
Finance income IFRSPrior1YearDuration6149000000JPY
Finance income IFRSCurrentYearDuration8110000000JPY
Interest expenses IFRSPrior1YearDuration2315000000JPY
Interest expenses IFRSCurrentYearDuration3217000000JPY
Loss on valuation of investments in funds IFRSPrior1YearDuration2414000000JPY
Loss on valuation of investments in funds IFRSCurrentYearDuration5159000000JPY
Other finance costs IFRSPrior1YearDuration219000000JPY
Other finance costs IFRSCurrentYearDuration403000000JPY
Finance costs IFRSPrior1YearDuration4949000000JPY
Finance costs IFRSCurrentYearDuration8779000000JPY
Buildings and structures acquisition cost IFRSPrior1YearInstant229864000000JPY
Machinery and vehicles acquisition cost IFRSPrior1YearInstant134956000000JPY
Tools furniture and fixtures acquisition cost IFRSPrior1YearInstant95716000000JPY
Land acquisition cost IFRSPrior1YearInstant17086000000JPY
Construction in progress acquisition cost IFRSPrior1YearInstant39827000000JPY
Right of use assets acquisition cost IFRSPrior1YearInstant106605000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2023-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass